Earlier this month, Cadila Pharmaceuticals signed an Investment Intention Form (IIF) with the Odisha government for setting up a state-of-the-art pharmaceutical formulation manufacturing unit under the state government’s newly-launched Industrial Policy 2022.
The multinational pharmaceutical company based in Ahmedabad focuses on manufacturing products ranging from API’s-Intermediates, finished formulations, OTC-Food Supplements, Biotechnology Products, and pharmaceutical Machinery.
0 Comment